 |
|
|
|
|
|
|
|
|
|
|
|
1 to 7 of 7 results |
|
 |
|
|
|
|
|
 |
|
|
|
|
Boche D, Nicoll J, Sakai K. on NEWS: Brain Drain—“Glymphatic” Pathway Clears Aβ, Requires Water Channel, We are intrigued by this important technological advance in helping to understand the fate of... 23 Aug 2012.
|
|
|
 |
|
|
Boche D, Nicoll J. on NEWS: Bapineuzumab Crops CSF Tau Levels, The interpretation that treatment of patients with the anti-Aβ monoclonal antibody bapineuzumab... 30 May 2012.
|
|
|
|
|
|
Boche D, Nicoll J. on PAPER: Sperling RA. et al., 2011, Is Prevention Better Than Cure?
The paper by Sperling and colleagues is a... 5 Dec 2011.
|
|
|
|
|
|
Boche D, Carare R, Hawkes C, Nicoll J, Weller R. on NEWS: Australia Report: Aβ Toxicity, ApoE, Failure of Perivascular Drainage of Aβ With Age and Its Relevance for Alzheimer's... 21 Oct 2011.
|
|
|
|
|
|
Boche D, Holmes C, Nicoll J. on NEWS: AD Clinical Pipeline: Immunotherapy Woes, Dimebon Boons, Our study was a six-year follow-up of patients in the original Elan AN1792 study of active... 18 Jul 2008.
|
|
|
|
|
|
Nicoll J. on NEWS: Hypertension Begets Aβ, Begets Cardiovascular Damage, Shin and colleagues have provided very interesting evidence of the physiological dysfunction... 18 Aug 2007.
|
|
|
|
|
|
Nicoll J. on NEWS: Philadelphia: Can a Shrinking Brain Be Good for You?, The brain volume changes in patients who were immunized and developed antibodies is interesting,... 11 Aug 2004.
|
|
|
|
|
|
|
1 to 7 of 7 results |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
The ALS Forum is a web-based collaborative effort to bring together valuable ALS-related resources for use by researchers worldwide in both academia and industry-based settings.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Should the FDA be allowed to use data from overseas clinical trials? |
|
|
|
|
|
|
|
|
|
|
|
Absolutely, we are running out of viable subjects in the U.S. |
|
|
|
|
|
|
 9 |
|
|
|
|
|
|
|
|
|
|
|
Yes, so long as the data is reliable |
|
|
|
|
|
|
31 |
|
|
|
|
|
|
|
|
|
|
|
No, the trials are not as rigorous |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
No, the data should be repeated in the U.S. |
|
|
|
|
|
|
5 |
|
|
|
|
|
|
|
|
|
|
|
No, the drug sponsors are just trying to cut corners |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
Responses: 51 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
Archived Polls |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
 Antibodies
Cell Lines
Collaborators
Papers
Research Participants
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Home
Check out our upcoming Webinar: 
